Age at menarche is not an independent risk factor for high-risk human papillomavirus infections and cervical intraepithelial neoplasia

International Journal of STD and AIDS

Volumn 19, Issue 1, 2008, Pages 16-25

  Syrjänen, Kari ^a   Shabalova, Irena ^b,c   Petrovichev, Nicolay ^b   Kozachenko, Vladimir ^b   Zakharova, Tatjana ^b   Pajanidi, Julia ^b   Podistov, Jurij ^b   Chemeris, Galina ^b   Sozaeva, Larisa ^c   Lipova, Elena ^c   Tsidaeva, Irena ^d   Ivanchenko, Olga ^d   Pshepurko, Alla ^d   Zakharenko, Sergej ^e   Nerovjna, Raisa ^f   Kljukina, Ludmila ^g   Erokhina, Oksana ^g   Branovskaja, Marina ^h   Nikitina, Maritta ^i,j   Grunberga, Valerija ^i,j   Grunberg, Alexandr ^i,j   Juschenko, Anna ⁱ   Santopietro, Rosa ^k   Cintorino, Marcella ^k   Tosi, Piero ^k   Syrjänen, Stina ^a,l,m   more..

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c Russian Medical Academy of Post Diploma Education   (Russian Federation)

^d Centralised Cytology Laboratory

^e Novgorod Municipal Dermatovenereological Dispensary ^*

^f Novgorod Female Consultative Outpatient Hospital   (Russian Federation)

^g National Oncology Center Bulgaria   (Bulgaria)

^h BELARUSIAN STATE MEDICAL UNIVERSITY   (Belarus)

ⁱ Latvian Cancer Centre

^j Laboratory of Cytology   (Latvia)

^k UNIVERSITY OF SIENA   (Italy)

^l Institute of Dentistry

^m UNIVERSITY OF TURKU   (Finland)

more..

Author keywords

Age; Cervical cancer; CIN; Delivery; HPV; Intercourse; Intervals; Menarche; Pregnancy; Risk factors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; CYTOLOGY; DELIVERY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; MENARCHE; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PREVALENCE; PRIMIGRAVIDA; PRIORITY JOURNAL; SEXUAL INTERCOURSE; UTERINE CERVIX CARCINOMA IN SITU; VERRUCA VULGARIS; AGE; CLASSIFICATION; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAPILLOMA VIRUS; PATHOLOGY; PREGNANCY; RISK FACTOR; SEXUAL BEHAVIOR; STATISTICS; TIME; VAGINA SMEAR; VIRUS INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; DELIVERY, OBSTETRIC; FEMALE; HUMANS; MENARCHE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; RISK FACTORS; SEXUAL BEHAVIOR; TIME FACTORS; VAGINAL SMEARS;

EID: 42949102643     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2007.007042     Document Type: Article

References (48)

1. Syrjänen K, Gissmann L, Koss LG, eds. Papillomaviruses and Human Disease. Berlin, Heidelberg: Springer Verlag, 1987:1-18
2. Syrjänen K, Syrjänen S. Papillomavirus Infections in Human Pathology. New York: J Wiley & Sons, 2000:1-15
3. Sellors JW, Mahony JB, Kaczorowski J, et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 2000;163:503-8
4. Kjellberg L, Hallmans G, Ahren AM, et al. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 2000;82:1332-8
5. Cavalcanti SM, Zardo LG, Passos MR, Oliveira LH. Epidemiological aspects of human papillomavirus infection and cervical cancer in Brazil. J Infect 2000;40:80-7
6. Lorincz AT, Castle PE, Sherman ME, et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 2002;360:228-9
7. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65
8. Hernandez-Hernandez DM, Ornelas-Bernal L, Guido-Jimenez M, et al. Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women. Gynecol Oncol 2003;90:310-17
9. Tjalma WA, van Waes TR, van den Eeden LE, Bogers JJ. Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Pract Res Clin Obstet Gynaecol 2005;19:469-83
10. Naud P, Matos J, Hammes L, et al. Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of Brazil. Eur J Obstet Gynecol Reprod Biol 2006;124:110-18
11. IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Papillomaviruses. vol. 64 Lyon: IARC Press, 1995:1-409
12. Aubin F, Pretet JL, Mougin C, eds. Papillomavirus Humains. Biologie et Pathologie Tumorale. Paris: Editions TEC & DOC, 2003:1-759
13. Syrjänen K, Väyrynen M, Castren O, et al. Sexual behaviour of women with human papillomavirus (HPV) lesions of the uterine cervix. Br J Vener Dis 1984;60:243-8
14. Kataja V, Syrjänen S, Yliskoski M, et al. Risk factors associated with cervical human papillomavirus infections: a case-control study. Am J Epidemiol 1993;138:735-45
15. Vaccarella S, Herrero R, Dai M, et al. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006;15:2148-53
16. Settheetham-Ishida W, Yuenyao P, Tassaneeyakul W, et al. Selected risk factors, human papillomavirus infection and the p53 codon 72 polymorphism in patients with squamous intraepithelial lesions in northeastern Thailand. Asian Pac J Cancer Prev 2006;7:113-8
17. Zhao FH, Forman MR, Belinson J, et al. Risk factors for HPV infection and cervical cancer among unscreened women in a high-risk rural area of China. Int J Cancer 2006;118:442-8
18. Castle PE, Walker JL, Schiffman M, Wheeler CM. Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology. Int J Cancer 2005;117:1007-12
19. Hernandez-Giron C, Smith JS, Lorincz A, Lazcano E, Hernandez-Avila M, Salmeron J. High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in Mexico. Sex Transm Dis 2005;32:613-18
20. Intyre-Seltman K, Castle PE, Guido R, Schiffman M, Wheeler CM. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev 2005;14:1165-70
21. Vaccarella S, Franceschi S, Herrero R, et al. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006;15:326-33
22. IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Hormonal Contraception and Postmenopausal Hormonal Therapy. vol. 72. Lyon: IARC Press, 1999:1-660
23. Moreno V, Bosch FX, Munoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 2002;359:1085-92
24. Green J, Berrington de Gonzalez A, Smith JS, et al. Human papillomavirus infection and use of oral contraceptives. Br J Cancer 2003;88:1713-20
25. Syrjänen S, Shabalova IP, Petrovichev N, et al. Oral contraceptives are not an independent risk factor for cervical intraepithelial neoplasia or high-risk human papillomavirus infections. Anticancer Res 2006;26:4729-40
26. Hildesheim A, Herrero R, Castle PE, et al. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 2001;84:1219-26
27. Giuliano AR, Papenfuss M, Abrahamsen M, et al. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev 2001;10:1129-36
28. Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001;183:1554-64
29. Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005;191:1796-807
30. Kahn JA, Rosenthal SL, Succop PA, Ho GY, Burk RD. Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics 2002;109:E5
31. Munoz N, Franceschi S, Bosetti C, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 2002;359:1093-01
32. Deacon JM, Evans CD, Yule R, et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 2000;83:1565-72
33. Smith EM, Ritchie JM, Levy BT, et al. Prevalence and persistence of human papillomavirus in postmenopausal age women. Cancer Detect Prev 2003;27:472-80
34. Winer RL, Koutsky LA. Human papillomavirus through the ages. J Infect Dis 2005;191:1787-9
35. ter Meulen J, Eberhardt HC, Luande J, et al. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, East Africa. Int J Cancer 1992;51:515-21
36. Collins SI, Mazloomzadeh S, Winter H, et al. Proximity of first intercourse to menarche and the risk of human papillomavirus infection: a longitudinal study. Int J Cancer 2005;114:498-500
37. Shew ML, Fortenberry JD, Miles P, Amortegui AJ. Interval between menarche and first sexual intercourse, related to risk of human papillomavirus infection. J Pediatr 1994;125:661-66
38. Kahn JA, Rosenthal SL, Succop PA, Ho GY, Burk RD. The interval between menarche and age of first sexual intercourse as a risk factor for subsequent HPV infection in adolescent and young adult women. J Pediatr 2002;141:718-23
39. Moscicki AB, Winkler B, Irwin Jr CE, Schacter J. Differences in biologic maturation, sexual behavior, and sexually transmitted disease between adolescents with and without cervical intraepithelial neoplasia. J Pediatr 1989;115:487-93
40. Syrjänen S, Shabalova IP, Petrovichev N, et al. Human papillomavirus testing and conventional PAP smear cytology as optional screening tools of women at different risk for cervical cancer in countries of former Soviet Union. J Low Genit Tract Dis 2002;6:97-110
41. Syrjänen S, Shabalova IP, Petrovichev N, et al. Sexual habits and human papillomavirus (HPV) infections among women in three new independent states of the former Soviet Union. Sex Transm Dis 2003;30:680-4
42. Syrjänen S, Shabalova IP, Petrovichev N, et al. Age-specific incidence and clearance rates of high-risk human papillomavirus (HPV) infections in women subjected to HPV screening in the new independent states. Int J STD AIDS 2005;16:217-33
43. Kulmala SM, Syrjänen S, Shabalova I, et al. Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol 2004;42:2470-5
44. Kanjanavirojkul N, Pairojkul C, Yuenyao P, Patarapadungkit N. Risk factors and histological outcome of abnormal cervix with human papilloma infection in Northeastern Thai women. Asian Pac J Cancer Prev 2006;7:567-70
45. Settheetham-Ishida W, Yuenyao P, Tassaneeyakul W, et al. Selected risk factors, human papillomavirus infection and the p53 codon 72 polymorphism in patients with squamous intraepithelial lesions in northeastern Thailand. Asian Pac J Cancer Prev 2006;7:113-18
46. Moscicki AB, Burt VG, Kanowitz S, Darragh T, Shiboski S. The significance of squamous metaplasia in the development of low grade squamous intraepithelial lesions in young women. Cancer 1999;85:1139-44
47. Syrjänen S, Shabalova IP, Petrovichev N, et al. Acquisition of incident high-risk human papillomavirus (HPV) DNA and PAP smear abnormalities in a cohort of women subjected to HPV screening in the New Independent States (NIS) of the former Soviet Union. J Clin Microbiol 2004;42:505-11
48. Syrjänen S, Shabalova IP, Petrovichev N, et al. Factors predicting persistence of high-risk human papillomavirus (HPV) infections in women prospectively followed-up in three New Independent States (NIS) of the former Soviet Union. Eur J Gynaecol Oncol 2005;26:491-8